Cantor Fitzgerald lowered the firm’s price target on DocGo to $11 from $13 and keeps an Overweight rating on the shares. The price target decrease reflects conservative adjustments to 2024 estimates and new 2024 guidance, the analyst tells investors in a research note. New contract growth in all core customer areas is strong, the firm adds.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DCGO: